William Warren, DPM
Foot & Ankle Surgery · Mineral Wells, TXNPI 1861578965
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,271 of the $1,868 with a category attached, or 68.0%. Pylant Medical accounts for 74.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $1,319 and has fallen 97.7% since, to $30 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in TX, where the typical reported total is $3,901.
Across 15 payments — averaging $124.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Stryker$222
- Orthofix Medical, Inc.$133
- Treace Medical Concepts, Inc.$53
- Amgen$35
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$15
- plus $26 from 2 others
What the payments were for
- Food & beverage$59732%
- Education$1,27168%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 4 | $1,384 |
| Stryker | 2 | $222 |
| Orthofix Medical, Inc. | 2 | $133 |
| Treace Medical Concepts, Inc. | 2 | $53 |
| Amgen | 2 | $35 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Globus Medical | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,868 in reported general payments places this provider in the 30th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 127 | $5,539 |
| Ciclopirox | 130 | $2,992 |
| Gabapentin | 132 | $1,418 |
| Ammonium Lactate | 57 | $1,248 |
| Febuxostat | 21 | $1,238 |
| Colchicine | 26 | $711 |
| Allopurinol | 77 | $495 |
| Clindamycin Hcl | 44 | $493 |
| Econazole Nitrate | 15 | $423 |
| Celecoxib | 19 | $273 |
| Terbinafine Hcl | 35 | $252 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $167 |
| Mupirocin | 17 | $163 |
| Meloxicam | 81 | $129 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $120 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Mineral Wells
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.